Parkinson's disease is one of the most common neurological diseases found in older men. Marked by a steady decline in ...
Legislation that would ban the use of paraquat, a fast-acting and highly toxic herbicide that studies have linked to ...
In April 2026, XellSmart officially launches its multicenter Phase II registrational clinical trial of the "Clinical-Grade, Allogeneic, Off-the-Shelf, iPSC-Derived, Dopaminergic Neural Progenitor Cell ...
UCSF Ralph Metzner Distinguished Professor in Neurology and Psychiatry Robin Carhart-Harris, PhD, is among the world’s first ...
Morning Overview on MSN
Early trial: BIIB094 cuts Parkinson’s-linked LRRK2 protein up to 60%
For the roughly one million Americans living with Parkinson’s disease, every approved treatment does the same thing: manage ...
No Doubt’s Tom Dumont, set to perform with Gwen Stefani, Tony Kanal, and Adrian Young in Las Vegas in May, shared he was ...
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that 18F-FD4 (R&D code: SST001), an α-synuclein (α-syn) targeted PET tracer ...
Parkinson’s disease is a serious condition that affects how people move and control their bodies. It usually develops slowly ...
Morning Overview on MSN
Study finds Alzheimer’s progresses differently in men vs. women’s brains
Nearly two out of every three Americans living with Alzheimer’s disease are women, according to the Alzheimer’s Association, ...
Peet is always waiting for the other shoe to drop. Except last year there seemed to be three different shoes, as she faced ...
A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results